Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
6.93
-0.31 (-4.28%)
At close: Feb 11, 2026, 4:00 PM EST
6.93
0.00 (0.00%)
After-hours: Feb 11, 2026, 4:10 PM EST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.35 billion as of February 11, 2026. Its market cap has decreased by -61.14% in one year.
Market Cap
2.35B
Enterprise Value
2.58B
1-Year Change
-61.14%
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $2.35B, an increase of 1,939.45%. That is a compound annual growth rate of 44.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.34B | -7.71% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.53B |
| Immunome | 2.51B |
| Wave Life Sciences | 2.41B |
| Mesoblast | 2.35B |
| Adaptive Biotechnologies | 2.32B |
| Mineralys Therapeutics | 2.29B |
| Ultragenyx Pharmaceutical | 2.27B |
| Ascentage Pharma Group International | 2.24B |